Pharmaceuticals - Community Register


List of nationally authorised medicinal products for human use


Product name: Cisapride
Also marketed in the EU under the name(s): Alimix, Arcasín, Bozaxtral, Cefanyl, Cevilor, Cipril, Circocric, Cisaprid-Janssen, Cisapride/Hexal, Ciside, Clotioride, Dolyzinax, Elpegon, Epasan, Evifix, Fisiogastrol, Gastridol, Hagasical, Kelosal, Kinussen, Lamafer, Lirebin, Minsk, Nastilox, Oferin, Prepulsid, Propulsin, Ruvetine, Saprimix, Spabucol, Systilan, Zenopar
Active substance: cisapride
Indication: Treatment of demonstrated pathological gastro-oesophageal reflux disease (GERD) after failure of
other treatment options in neonates, infants and children up to 36 months of age.
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
3/06/2002 Referral EMEA/H/A-12/367 (2002)2055 of 30/05/2002